Caladrius Biosciences, a cell therapy company with a select therapeutic development pipeline focused on immune modulation, partnered with us to develop a unique platform that enables cell therapy developers to wash and concentrate cells in a closed environment through the combination of a fluidics and counterflow centrifuge system. Given our considerable experience and track record in cell therapy automation and knowledge of counterflow centrifugation technology, we developed the hardware and handled the manufacturing of this platform.
The result is a Counterflow Centrifuge Device (CFC) platform that offers flexibility and applicability in the research and development of therapies. The device can also be used in the commercial production of therapies as they achieve regulatory approvals.